today show glp 1 Medicare to Cover GLP-1 Weight Loss Drugs for $50 a Month NBC6 Responds: Consumer groups warn

workers offers some insight into workplace expectations around weight loss treatments

With Novo Holdings $16.5 billion buyout of Catalent being reviewed by regulators, what work the contract drug manufacturer may or may not be performing for Eli Lilly remains a point of contention.

Exendin-4 is less prone to enzymatic degradation, but it is still unclear what other factors contribute to the increased metabolic stability

Should you taper GLP-1 drugs like semaglutide before stopping

Two recently developed methods for visually presenting complex weight and health-risk information that encapsulate substantial amounts of clinical trial observations were recently developed that can potentially supplement and give new insights into conventional GLP-1R agonist scientific reports